Sex is Good Podcast
Sex is Good.
And we’re done pretending otherwise.
The Sex Is Good podcast exists to say the quiet part out loud: sex is fun, sex is normal, and sex is something adults get to enjoy without shame, fear, or bad information.
Hosted by the founder of a sex-positive telehealth company and a medical provider who actually understands how bodies work in the real world, this podcast breaks down the science of sex, STIs, desire, performance, relationships, and pleasure — without pearl-clutching, scare tactics, or outdated sex-ed nonsense.
We talk about the things you weren’t taught in school.
We unlearn the myths you were taught.
And we remind you that having a great sex life and taking care of your sexual health are not opposites — they’re partners.
Yes, we talk about STIs.
Yes, we talk about testing and prevention.
And no, that doesn’t mean sex has to be boring, stressful, or wrapped in shame.
You can absolutely have your cake and eat it too. You can have a wild, fulfilling, adventurous sex life and be informed, responsible, and confident about your health. In fact, we’d argue that’s the whole point.
This isn’t a sex story podcast.
It’s a sex science, sex truth, and sex freedom podcast.
Smart, evidence-based, irreverent, and unapologetically pro-pleasure.
Because sex is good. And we’re done pretending it’s not.
Sex is Good Podcast
DoxyPEP and women - The truth shall set us free.
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
DoxyPEP is one of the most powerful STI prevention tools we’ve ever had—if you actually take it.
In 2023, a high-profile study out of Kenya made headlines: Doxycycline PEP didn’t work for cisgender women. News outlets ran with the soundbite, and suddenly the internet decided: “DoxyPEP doesn’t work for women.” But what if we told you… that wasn’t the whole truth?
In this episode, Robert and Anna take a deep dive into the original study and explain why the results were wildly misinterpreted. Yes, the study failed to show benefit—but it also failed to prove that the women actually took their pills. In fact, over 50% of participants who said they used DoxyPEP had no measurable doxycycline in their system. That’s not a failed drug. That’s failed adherence.
We also break down what the media got wrong, how “science by press release” can backfire, and why this misunderstanding has already caused real-world harm—preventing many cisgender women from accessing a safe, effective, and affordable STI prevention option.
And just when you think it’s all bad news? Enter the 2024 Tokyo study. Real-world data. High adherence. Cisgender women. And what did they find? DoxyPEP worked. Really well.
We unpack all of it.
This episode is for the curious, the skeptical, and anyone tired of being told “that’s not for you” without the receipts. We believe in sex-positive science, evidence over headlines, and that women deserve access to every tool in the STI prevention toolkit.
Especially when it works.
Shameless Care is one of the few places in the U.S. where cisgender women can get DoxyPEP—prescribed by a board-certified doctor, with no BS and no shame.
Let’s set the record straight.
#DoxyPEP #WomensHealth #STIPrevention #CisWomen #SexPositiveMedicine #SexualHealth #ScienceOverHype #AntibioticResistance #NEJM #TokyoStudy #ShamelessCarePodcast #SexEd #PublicHealth #EvidenceBased #Gonorrhea #Chlamydia #Doxycycline #MyBodyMyData #HealthFreedom #RealScience #STIAwareness #ScienceNotShame